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Homotransplantation of the liver in a patient 
with hepatoma and hereditary tyrosinemia 
A girl with hereditary tyrosinemia, diagnosed at 6 months of age. was treated with a diet restricted in 
phenylalanine QIfd tyrosine. A I 9'h years of age she developed QIf acutely enlarged liver and spleen. and 
the diagnosis of hepatocarcinoma was mode. The patient received a liver transplant and Iyrosine 
fnelObolites become normal while she was receiving a regular diet. Three months laler. an infected 
thrombosis of the portal vein caused her death. Liver Iransplant appears 10 be an effective method of 
en:yme replacement in tyrosinemia and should be considered for prevention of hepatoma . 
Robert O. Fisch, M.D.,· Minneapolis, Minn., 
Edward R. B. McCabe, M.D., Ph.D., Denver, Colo., Doris Doeden, M.S., 
Minneapolis, Minn., Lawrence J. Koep, M.D., Jerry G. Kohlhoff, B.A., 
Arnold Silverman, M.D., and Thomas E. Starzl, M.D., Denver, Colo. 
HEREDITARY TYROSINEMIA is a disorder character-
ized by hypertyrosinemia. tyrosinuria. marked excretion 
of tyrosine metabolites in the urine (tyrosyluria). liver 
disease. and renal tubular dysfunction. p-Hydroxyphenyl-
pyruvic acid oxidase (4-hydroxyphenylpyruvate: oxygen 
oxidoreductase [hydroxylating. decarboxylatingJ. EC 
1.13.11.27) has been shown to be deficient in the livers of 
patients with hereditary tyrosinemia. but it is not clear 
that this is the primary enzymatic deficiency.' Recently. 
evidence has been presented suggesting a defiCiency of 
another enzjme in tyrosine catabolism. fumarylacetoace-
laSe (4-fumarylacetoacetate fumarylehydrolase. EC 
3.7.1.2). in this disease.' Tyrosinemia and tyrosyluria can 
be found in liver disease due to other causes. notably. 
hereditary fructose intolerance." 3 
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The liver disease in hereditary tyrosinemia 
progressive hepatocytic atrophy with fibrosis and 
regeneration.' Hepatoma is a significant cofatribu:tot:~~ 
death in patients surviving beyond infancy.' AltJlOt_cJ'!l. 
dietary restriction of phenylalanine and tyrosine will 
to improvement of tyrosinemia. tyrosyluria. growth, .' 
renal tubular dysfunction,>,· it is not clear that this 
alter progression of pathologic changes in the liver 
lead ultimately to the development of hepat~:::j . 
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Abbreviations used . ;jti 
ALA: delta-aminolevulinic acid .... ''$':' 
ALA-D: ALA-dehydratase 'd '. ~~iiK: 
pHPPA:p-hydroxyphenylpyruvic aCl .• 
CASE ob~:~m-hydroDFsh .. yn"", .ci<\ I~~tK 
The patient weighed 3.458 gm at binh; pregnancy and deli""D~1D , 
were uncomplicated. She began vomiting at 2 months or ~gi 
Later she developed abdominal distention. periorbital ~K 
and increasing ascites. At six months of age she was admiue4"· "'; 
the University of Minnesota Medical Center. ", r 
Exploratory laparotomy revealed enlargement of the Ii¥fI ,. 
kidneys. The spleen was nonnal. Biopsies revealed cirrboIitJi 
the liver and focal calcification of the kidneys. .·,tit' 
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~: TIbie I. Results of serum and urinary tyrosine metabolites. urinary ALA. ALA-D. and 
protoporphyrin in red blood cells 
'-
I wk 
On On prior to I] wk after 
regular restricted transplant ] days 0.5-1 I wk transplanl 
diet 5-6 diet 6 rna on restricted after after (week 
Normal me a/age 9~yr diet transplant transplant prior to 
values (N - 3) (.IV ~ 5]) (S - /) (N - I) (N - 7-10) death) 
Serum tyrosine (mg/dl) Mean 2.47' Mean 13.2 Range 0.7-6.3 3.83 0.72 Range 0.59- I.2S 1.1-1.2 
SO ± 0.97 Mean 3.29 Mean 0.79 
SO ± 1.16 
Urine tyrosine (3-12 yr)'· 377.0 73.5 Range 62.5-223.0 46.8 
(}Imol124 hr) Range 40-168 Mean 136 
Urine pHHPA and Range 0.0-0.3'· Mean 19.0 Range tr-24.0 6.85 0 Range 0-0.16 0.19 
pHPlA (J.Imol/ml) Mean 2.62 Mean 0.11 
SO ± 4.0 
Urine ALA (mg/liter) Range 0.0-5.4" Mean 5.57 Range 3.0-37.0 34.4 3.48 Range 3.1-10.0 9.4 
Mean 2.2 Mean 20.5 Mean 4.94 
SO ± 3.34 
IUIC ALA·O (J.Imol Range 22.4-44.5" Mean <6.0 
ALA/min/liter RBe) Mean 33 N .. 20 
SO:!: 4.8 
IBC protoporphyrin Range 22.0-87.0" Range 84.0-95.0 
(pg/d1) Mean 46.0 Mean 93.3 
SO ± 14 SO ± 10.4 
N - 3 
Abnormal liver function tests included clotting studies uncor· 
~ by vitamin K. Metabolic studies revealed hypertyrosine-
mil. tyrosyluria. and aminoaciduria. suggesting a diagnosis of 
"bereditary tyrosinemia" (Table \). 
She was given a diet low in tyrosine and phenylalanine 
(A8-3200. Mead Johnson) at 7 months of age. She was hospital-
ized twice during her first year of life for dietary readjustment 
aad was followed at approximately monthly intervals for clinical 
ud laboratory evaluation which included routine assessment of 
IenJm tyrosine and urinary tyrosine metabolites. With the excep-
tioo of two episodes of urinary tract infection, her course was 
. IIIICOmplicated over the first nine years. Intellectual development >, 
was DOrmal and activity was unrestricted. Ambulatory dietary 
,. -dllDagement in her ninth year provided tyrosine 35 mg/leg/day, 
Ji*ylaJanine 41 mg/leg/day, and protein 2.1 gm/leg/day. 
measures at the last outpatient evaluation at 9'/" years 
weight 27.3 kg (twenty-fifth percentile). height 130.9 cm 
_tv-lifth percentile). and head circumference 52 em (fortieth 
~~t~~~feFK At that time the liver was 2 to 3 cm below the right 
and the spleen was 10 em below the left costal 
ramily history was unremar\cable; the parents and three 
~ in good health. 
was admitted two weeks later to the University of 
!l!~g~triesllta Medical Center with acute onset of abdominal pain 
an enlarging spleen. There was no preceding history of 
or infection. On physical examination a nodular liver was 
3.5 em below the right costal margin. and the spleen 
·I:u;~"ienliled 16 em below the left costal margin with a 10 cm width. 
laboratory findings at this time included hemoglobin 9.1 gm/dt. 
2.000 white blood cells/mm', 51,000 platelets/mm'. BUN 21 
mg/d!, and creatinine 0.1 mg/dl. 
A liver-spleen scan revealed a discrete filling defect in the right 
lobe of the liver and an enlarged spleen. An angiogram of the 
liver and spleen showed abnormal vasculature in the right lobe of 
the liver and massive splenomegaly without evidence of a splenic 
vascular accident. Bone marrow examination and multiple l(·ray 
examinations did not demonstrate mestastases. The patient was 
subjected to exploratory laparotomy and open liver biopsy. 
Findings at surgery included regenerative macronodular cirrhosis 
and an area of firm tumor on the right lobe of the liver. Biopsies 
of the mass confirmed a diagnosis of hepatocellular carcinoma of 
the right lobe of the liver. Severe macronodular cirrhosis 
precluded resection. 
Additional laboratory results included negative alpha fetopra-
tein, elevated gamma glutamyltranspeptidase (54 IU II). alkaline 
phosphatase 578 run. SOOT 78 IU/I. and negative heterophil 
antibody test. Serum electrophoresis revealed a twice normal 
elevation of alpba-I fraction (0.41 gm/dl), trypsin inhibitory 
capacity 2.06 mg (normal 0.25 to 1.2 mg). and carcinoembryonic 
antigen O.l/ng ml (normal < 2.0/ng ml). 
She was transferred to the Univemty or Colorado Medical 
Center. Additional investigation revealed no evidence of metas-
tatic disease, and two weeks after admission she underwent total 
hepatectomy and orthotopic liver transplantation. The liver. 
weighing 1,450 gm. was cirrhotic with bepatocellular carcinoma 
invading the portal vein. Blood pressure gradually rose to a high 
of 1921124 on the second postoperative day; this responded to 
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Table II. Demonstration of normal aldolase activity in 
patient's native liver after hepatectomy· 
Substrate 
Fructose-I, Fructose-
Liver 6-diphospluJle l-phospluJre FDP/F-I-P 
Control 26.7 22.0 1.2 
Patient 37.4-43.5 30.2-26.8 1.2-1.6 
·Enzyme aaivity is expressed I15l18Damoles NAD formeci/m, protein min 
at 37· utiliz:ins the assay of bolstein and Rutter. I. 
Table m. Zinc concentrations in urine, plasma, and red 
blood cells 
Period 1974-1975 
Normal" Range I N I Mean 
Urine 0.4-0.6 0.006-0.05 5 0.036 
zinc (mg/24°) 
Plasma 0.89 ± 0.13 0.64-0.58 2 0.61 
zinc (J.Lg/ml) 
RBC 10.1 ± 1.2 10.7-15.4 2 13.0 
zinc (gIn/mI) 
reserpine and hydralazine therapy. Four days postoperatively she 
had symptoms oflefi-parietal occipital infarct, but there were no 
permanent residua. Beginning on the fifth postoperative day and 
extending until her preterminal deterioration nine weeks later, 
she was allowed a diet unrestricted in quality and quantity. 
Following transplantation. serum I)Tosine concentratioDS. all but 
one urinary examination of urine tyrosine values. and all 
measurements of urinary and tyrosine metabolites were within 
normal limits (fable I). She was walking within two days after 
surgery. She was active and allowed to spend the weekends out of 
the hospital, participating in multiple activities for two months. 
Four weeks postoperatively she had her first rejection episode. 
requiring increased doses of steroids. Bilirubin. SOOT, SGPT. 
and alkaline phosphatase values temporarily improved but never 
returned to prerejection levels. Contrast injection through the 
cboledochojejunostomy stint revealed no obstruction to biliary 
drainage. and the stint was removed. Six weeks following 
transplant a percutaneous liver biopsy was performed because of 
persistently elevated hepatic enzyme values. This revealed mono-
nuclear infiltration of the ponal tracts with centrilobular choles-
tasis. compatible with panially treated rejection. 
Ten weeks after transplant she developed abdominal pain with 
increasing ascites. She became febrile. and Staphylococcus au reus 
was cultured from her blood. A paronychia was drained. She was 
given cefazolin and gentamicin parenterally. All liver enzyme 
values rose rapidly but HB,Ag remained negative. A repeat 
percutaneous liver biopsy performed 11 weeks posloperatively 
showed deterioration. with marked cholestasis and central and 
lobular necrosis. 
With deteriorating hepatic function she developed encephalo-
pathy. Because the encephalopathy did not respond to conven-
tional management. and dotting function was declining. 
exploratory operation was performed 12 weeks after 
lion. Ponal vein thrombosis with suppurative pylleplhle1bitil) 
discovered. Gram stain from the portal vein revealed 
positive cocci in dusters. She had cardiac arrest during 
and could Dot be resuscitated. Autopsy revealed no 
ings. 
METHODS 
Serum tyrosine and phenylalanine aet..cnnllllattODllJ 
performed according to the methods of Phillips,' 
McCaman and Robins." Urinary tyrosine 
were determined by gas chromatography after 
methyl este's, using the diazomethane method.' 
tyrosine was quantitated by the method of 
Paska. '0 Urinary delta-amino levulinic acid 
tions were measured as reported by Tomokuni ei 
ALA-dehydratase activity of red blood cells was 
determined.': Determinations of urine and plasma 
were made by atomic absorption 
following the specified collection procedure." mrcltl~lCFl"Ifc 
phyrin of red blood cells was also determined." 
aldolase activity was measured sPlcctrol)h(){omc:tri.caJllYl! 
means of the coupled reactions described by Bolst~ 
Rutter.'6 The laboratory results are summarized in 
I to III . 
DISCUSSION 
This patient's presentation and physical and laboralqfJlt"!.:: 
findings are typical of hereditary tyrosinemia, with 
improvement of the metabolic studies after dietary 
tion of tyrosine and phenylalanine .. Hereditary fmf~~I 
intolerance (hepatic aldolase deficiency) can present 
similar fashion,'" but this patient's liver had 
aldolase activity (Table II). and she responded biocbeitAllt 
cally to a diet restricted in tyrosine and phenylalanine. ' 
unrestricted in fructose. Although our patient did: 
have evidence of vitamin D-resistant rickets, she did 
intermittent porphyria," elevated urinary ALA 
es,z°' :, and evidence of ALA-D deficiency (Table 
patient is among the first with tyrosinemia in 
decreased red cell activity of zinc-dependent 
ALA-D. and zinc deficiency as measured by diglfliaifpll1~K 
levels in plasma and urine, have been 
(Table 1Il). The appearance of hepatoma is Cfla:raclCnll~ .. 
of patients with hereditary tyrosinemia. even in the 
treated with tyrosine and phenylalanine restricted 
Hepatocarcinoma usually appears in children over 
age of 5 years: one third of the cases are associated 
cirrhosis:~: 37% of patients with hereditary tyJ'101Si111181!!!t1 
surviving beyond 2 years of age develop he~FUtcKcar~ 
ma.' The median age at the time of death has 
years, with a range of 4 to,25 years. Hepatoma 
in 66% of the females and 57% of the males. 
of tumor among patients with hereditary 
is far greater' than the incidence of this tumor 
'ed adults with cirrhosis (4.4% of adult 
17.5% of adult males. for an overall incidence 
suggesting that factors other than the mere 
of cirrhosis are associated with the induction of 
in tyrosinemia. The coexistence of cirrhosis and 
aJ'CUlOmla also distinguishes the tyrosinemic chil-
others with this tumor. since in contrast to 
association is relatively infrequent in the 
population. "' 
fctoprotein would not seem to be of diagnostic 
these patients. since this may be elevated in the 
tumor." and may be within normal limits in 
of hepatoma. as seen in this patient and 
Thus. isotopic liver scan might be considered 
management of patients with hereditary 
hepatocarcinoma is uniformly fatal. The 
from the time of diagnosis of 47 untreated 
with primary cancer of the liver ranged from ont' 
months, with a mean of five months." 
McCary'· reported a series of 47 pediatric 
had been managed with surgical resection of 
: 27 were alive. 15 without metastasis, 
of these patients were well at least five years 
their resection. A recent survey of 16 pediatric 
clinics indicated that the two-year survival with 
1itOc:elllJ\ar carcinoma was only one out of eight. with 
beyond five years of age." Radiation and 
drugs usually had little effect on these hepatic 
lobectomy. hemihepatectomy, or extended 
lfpactectomlY were the opera tions of choice." The 
cirrhosis of patients with hereditary tyrosi-
hepatoma markedly increases the operative 
as in our patient. precludes surgical resection. 
in these patients are then to do nothing, to 
~ ....... u"" (i.e., radiation and drugs) which appear 
positive benefit, or to consider liver transplanta-
the first liver transplantation in 1963. 119 have 
II!!I'Iorwt.'l1 JT • ., In one report. more than half of the 
children .. " Hepatoma was the most common 
liver transplantation for adults, and second for 
replacement through orthotopic liver trans-
for inherited metabolic disorders has been 
reported for Wilson disease (two patients), 
deficiency (one patient),'" and for 
disease (one patient)."" These patients have 
"mn/ll:J(able one-year survival of 100% and succcss-
H omolral1SplanlQlion of the liver 595 
ful treatment of the metabolic defect. The patient with 
Nieman-Pick disease was operated on at 2 years of age; 
following liver transplantation. not only did enzymatic 
function resume, but clouding of the cornea quickly 
disappeared, together with a definite regression of the 
lipid infiltrate in the retinas .... 
In the current management of hereditary tyrosinemia, 
the only supportive measure is dietary restriction; enzy-
matic replacement therapy is not available. In spite of the 
rejection symptoms and the terminal outcome, our patient 
demonstrates that hepatic transplantation does alleviate 
the metabolic abnormalities of the liver and kidney in this 
disorder. A recommendation for routine liver transplanta-
tion in this disease might be considered, understandably. 
an overly aggressive posture. However, increasing experi-
ence, improving technical skill, better preservation of 
livers. and immunologic support will inevitably produce 
more successful hepatic transplants. 
Appropriate timing of transplantation would not only 
restore normal tyrosine function and other liver functions, 
but ideally could prevent the complications of severe 
cirrhosis and portal hypertension. and might help prevent 
hepatoma. 
We thank Mr. William H. Scruton for his assistance with heavy 
metal determinations by the Minnesota Department of Health. 
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